These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 26118442)
1. Synthesis and characterization of a PAMAM dendrimer nanocarrier functionalized by SRL peptide for targeted gene delivery to the brain. Zarebkohan A; Najafi F; Moghimi HR; Hemmati M; Deevband MR; Kazemi B Eur J Pharm Sci; 2015 Oct; 78():19-30. PubMed ID: 26118442 [TBL] [Abstract][Full Text] [Related]
2. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. Ke W; Shao K; Huang R; Han L; Liu Y; Li J; Kuang Y; Ye L; Lou J; Jiang C Biomaterials; 2009 Dec; 30(36):6976-85. PubMed ID: 19765819 [TBL] [Abstract][Full Text] [Related]
3. Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. Huang RQ; Qu YH; Ke WL; Zhu JH; Pei YY; Jiang C FASEB J; 2007 Apr; 21(4):1117-25. PubMed ID: 17218540 [TBL] [Abstract][Full Text] [Related]
4. Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles. Liu Y; Huang R; Han L; Ke W; Shao K; Ye L; Lou J; Jiang C Biomaterials; 2009 Sep; 30(25):4195-202. PubMed ID: 19467700 [TBL] [Abstract][Full Text] [Related]
5. Modulated cellular delivery of anti-VEGF siRNA (bevasiranib) by incorporating supramolecular assemblies of hydrophobically modified polyamidoamine dendrimer in stealth liposomes. Golkar N; Samani SM; Tamaddon AM Int J Pharm; 2016 Aug; 510(1):30-41. PubMed ID: 27291973 [TBL] [Abstract][Full Text] [Related]
6. Polyamidoamine (PAMAM) dendrimers modified with short oligopeptides for early endosomal escape and enhanced gene delivery. Thuy le T; Mallick S; Choi JS Int J Pharm; 2015 Aug; 492(1-2):233-43. PubMed ID: 26187169 [TBL] [Abstract][Full Text] [Related]
7. Targeted delivery of chlorotoxin-modified DNA-loaded nanoparticles to glioma via intravenous administration. Huang R; Ke W; Han L; Li J; Liu S; Jiang C Biomaterials; 2011 Mar; 32(9):2399-406. PubMed ID: 21185076 [TBL] [Abstract][Full Text] [Related]
8. Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma. Huang S; Li J; Han L; Liu S; Ma H; Huang R; Jiang C Biomaterials; 2011 Oct; 32(28):6832-8. PubMed ID: 21700333 [TBL] [Abstract][Full Text] [Related]
9. SRL-Coated PAMAM Dendrimer Nano-Carrier for Targeted Gene Delivery to the Glioma Cells and Competitive Inhibition by Lactoferrin. Zarebkohan A; Najafi F; Moghimi HR; Hemmati M; Deevband MR; Kazemi B Iran J Pharm Res; 2016; 15(4):629-640. PubMed ID: 28243262 [TBL] [Abstract][Full Text] [Related]
10. T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting. Kuang Y; An S; Guo Y; Huang S; Shao K; Liu Y; Li J; Ma H; Jiang C Int J Pharm; 2013 Sep; 454(1):11-20. PubMed ID: 23867728 [TBL] [Abstract][Full Text] [Related]
11. Nanocarriers and the delivered drug: effect interference due to intravenous administration. Vlasova MA; Rytkönen J; Riikonen J; Tarasova OS; Mönkäre J; Kovalainen M; Närvänen A; Salonen J; Herzig KH; Lehto VP; Järvinen K Eur J Pharm Sci; 2014 Oct; 63():96-102. PubMed ID: 24964293 [TBL] [Abstract][Full Text] [Related]
12. Chondrocyte affinity peptide modified PAMAM conjugate as a nanoplatform for targeting and retention in cartilage. Hu Q; Chen Q; Yan X; Ding B; Chen D; Cheng L Nanomedicine (Lond); 2018 Apr; 13(7):749-767. PubMed ID: 29528264 [TBL] [Abstract][Full Text] [Related]
13. Brain-targeting mechanisms of lactoferrin-modified DNA-loaded nanoparticles. Huang R; Ke W; Han L; Liu Y; Shao K; Ye L; Lou J; Jiang C; Pei Y J Cereb Blood Flow Metab; 2009 Dec; 29(12):1914-23. PubMed ID: 19654588 [TBL] [Abstract][Full Text] [Related]
14. PEGylated Polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma. Jiang Y; Lv L; Shi H; Hua Y; Lv W; Wang X; Xin H; Xu Q Colloids Surf B Biointerfaces; 2016 Nov; 147():242-249. PubMed ID: 27518456 [TBL] [Abstract][Full Text] [Related]
15. Poly (amidoamine) dendrimer-mediated hybrid formulation for combination therapy of ramipril and hydrochlorothiazide. Singh MK; Pooja D; Kulhari H; Jain SK; Sistla R; Chauhan AS Eur J Pharm Sci; 2017 Jan; 96():84-92. PubMed ID: 27614111 [TBL] [Abstract][Full Text] [Related]
16. PEGylated poly(2-(dimethylamino) ethyl methacrylate)/DNA polyplex micelles decorated with phage-displayed TGN peptide for brain-targeted gene delivery. Qian Y; Zha Y; Feng B; Pang Z; Zhang B; Sun X; Ren J; Zhang C; Shao X; Zhang Q; Jiang X Biomaterials; 2013 Mar; 34(8):2117-29. PubMed ID: 23245924 [TBL] [Abstract][Full Text] [Related]
17. Plasmid pORF-hTRAIL targeting to glioma using transferrin-modified polyamidoamine dendrimer. Gao S; Li J; Jiang C; Hong B; Hao B Drug Des Devel Ther; 2016; 10():1-11. PubMed ID: 26719669 [TBL] [Abstract][Full Text] [Related]
18. The role of caveolin-1 and syndecan-4 in the internalization of PEGylated PAMAM dendrimer polyplexes into myoblast and hepatic cells. Shen W; van Dongen MA; Han Y; Yu M; Li Y; Liu G; Banaszak Holl MM; Qi R Eur J Pharm Biopharm; 2014 Nov; 88(3):658-63. PubMed ID: 25083608 [TBL] [Abstract][Full Text] [Related]
19. Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery. Souza JG; Dias K; Silva SA; de Rezende LC; Rocha EM; Emery FS; Lopez RF J Control Release; 2015 Feb; 200():115-24. PubMed ID: 25553828 [TBL] [Abstract][Full Text] [Related]
20. Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy. Li J; Liang H; Liu J; Wang Z Int J Pharm; 2018 Jul; 546(1-2):215-225. PubMed ID: 29787895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]